{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"thymosin-alpha-1-skin","title":"Thymosin Alpha 1 for Skin: Evidence-Graded Review","body":"## What's breaking down\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\n\n## Why Thymosin Alpha-1 might help you\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\n\n## How these fit together\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\n\n## What the evidence actually shows\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigue or infections.\n\n## What scientists say\nReviews note immune-modulating roles in melanoma and potential for autoimmune skin-related conditions via restored T-cell function and reduced excessive inflammation. Wound-healing data remain animal-based. Larger human trials for dermatologic uses are absent.\n\n## What people say on Reddit\nPosts rarely focus on skin specifically. General peptide discussions mention immune support but lack detailed skin-before/after reports.\n\n## What people say on X\nSparse mentions; no prominent skin-specific anecdotes identified in searches.\n\n## What we do not know\nDirect effects on human skin barrier repair, psoriasis plaques, or chronic wounds lack dedicated trials. Long-term skin outcomes and optimal contexts remain untested in large populations. Correlation of low levels in psoriatic arthritis does not prove causation or treatment effect.\n\n## Safety and limits\nClinical reviews of over 11,000 subjects across trials describe it as generally well-tolerated. No skin-specific safety signals reported in available data. Individual responses vary; consult research literature for full context.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/thymosin-alpha-1-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Serum thymosin alpha-1 levels were significantly lower in psoriatic arthritis patients compared to healthy controls in a 2016 human study of 320 subjects.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Links lower endogenous levels to a skin/joint autoimmune condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Thymosin alpha-1 stimulated endothelial cell migration, angiogenesis, and accelerated wound healing in a 1998 animal study using subcutaneous and topical administration in punch wound models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Provides mechanistic repair data relevant to skin.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In human phase II melanoma trials, thymosin alpha-1 combined with dacarbazine increased objective response rates threefold versus dacarbazine alone.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct human evidence in a skin cancer context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5011367/","title":"Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases","quote":"Patients had lower serum Tα1 levels than HC (p<0.0001), the lowest were observed in PsA group (p< 0.0001 vs all the other groups).","summary":"Human observational study measuring serum TA-1 in autoimmune patients including PsA.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"7bea83a89a395167e60bedffd34ba7c4e01db6d0672c675e9d2d102ed38b4fc8"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9551940/","title":"Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing","quote":"When given either topically or i.p., it accelerated wound healing in a punch model, demonstrating that Talpha1 promotes angiogenesis and wound healing.","summary":"Preclinical animal study on wound healing effects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"verified","prev":"7bea83a89a395167e60bedffd34ba7c4e01db6d0672c675e9d2d102ed38b4fc8","hash":"da12a15343911d54621558313a10ee808a2238bf213961826a8e2db5dd4c15bd"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/30063847/","title":"Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1","quote":"Thymosin alpha-1 (Tα1) with dacarbazine (DTIC) showed activity in a phase II trial...","summary":"Human clinical data on melanoma response rates.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"unverified","prev":"da12a15343911d54621558313a10ee808a2238bf213961826a8e2db5dd4c15bd","hash":"a37396b83bc22d94c1bd06b4634c2fa17aaa878bbf8ec2cc6e42755fdd997f9f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:56:58.308Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Thymosin Alpha 1 for Skin: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\n\n## Why Thymosin Alpha-1 might help you\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\n\n## How these fit together\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\n\n## What the evidence actually shows\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigue or infections.\n\n## What scientists say\nReviews note immune-modulating roles in melanoma and potential for autoimmune skin-related conditions via restored T-cell function and reduced excessive inflammation. Wound-healing data remain animal-based. Larger human trials for dermatologic uses are absent.\n\n## What people say on Reddit\nPosts rarely focus on skin specifically. General peptide discussions mention immune support but lack detailed skin-before/after reports.\n\n## What people say on X\nSparse mentions; no prominent skin-specific anecdotes identified in searches.\n\n## What we do not know\nDirect effects on human skin barrier repair, psoriasis plaques, or chronic wounds lack dedicated trials. Long-term skin outcomes and optimal contexts remain untested in large populations. Correlation of low levels in psoriatic arthritis does not prove causation or treatment effect.\n\n## Safety and limits\nClinical reviews of over 11,000 subjects across trials describe it as generally well-tolerated. No skin-specific safety signals reported in available data. Individual responses vary; consult research literature for full context.","claims":[{"id":"c1","text":"Serum thymosin alpha-1 levels were significantly lower in psoriatic arthritis patients compared to healthy controls in a 2016 human study of 320 subjects.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Links lower endogenous levels to a skin/joint autoimmune condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Thymosin alpha-1 stimulated endothelial cell migration, angiogenesis, and accelerated wound healing in a 1998 animal study using subcutaneous and topical administration in punch wound models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Provides mechanistic repair data relevant to skin.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In human phase II melanoma trials, thymosin alpha-1 combined with dacarbazine increased objective response rates threefold versus dacarbazine alone.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct human evidence in a skin cancer context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5011367/","title":"Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases","quote":"Patients had lower serum Tα1 levels than HC (p<0.0001), the lowest were observed in PsA group (p< 0.0001 vs all the other groups).","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9551940/","title":"Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing","quote":"When given either topically or i.p., it accelerated wound healing in a punch model, demonstrating that Talpha1 promotes angiogenesis and wound healing.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/30063847/","title":"Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1","quote":"Thymosin alpha-1 (Tα1) with dacarbazine (DTIC) showed activity in a phase II trial...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":31088,"tokens_out":2495,"cost":0.0450975,"prev_hash":"genesis","hash":"11da711b6a9f4bf9db5bb6f47a3eb26896655b566d0aeee2d0a256f7715c6f55"}],"provenance":[{"ts":"2026-06-29T22:56:58.308Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Thymosin Alpha 1 for Skin\nSlug: thymosin-alpha-1-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\",\"section_title\":\"Why Thymosin Alpha-1 might help you\",\"layer\":\"immune modulation\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Thymosin Alpha-1** → immune modulation\",\"section_headings\":[\"What's breaking down\",\"Why Thymosin Alpha-1 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chai","response":"{\n  \"slug\": \"thymosin-alpha-1-skin\",\n  \"title\": \"Thymosin Alpha 1 for Skin: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\\n\\n## Why Thymosin Alpha-1 might help you\\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\\n\\n## How these fit together\\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\\n\\n## What the evidence actually shows\\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigu","tokens_in":31088,"tokens_out":2495,"cost":0,"prev":"genesis","hash":"57b599aefb0c610213a5630d465eb2a6100861d2c80e15ecebc896ce66f6070a"},{"ts":"2026-07-17T02:43:11.676Z","model":"owner","action":"voxel_divide","prompt":"","input":"thymosin-alpha-1-skin","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"57b599aefb0c610213a5630d465eb2a6100861d2c80e15ecebc896ce66f6070a","hash":"8c4657b588cb633087370631c4d68c26ef95d553ce47b4ebf702bd5abccbb672"}],"energy":{"passes":2,"tokens_in":31088,"tokens_out":2495,"tokens_total":33583,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8c4657b588cb633087370631c4d68c26ef95d553ce47b4ebf702bd5abccbb672"},"posted_at":"2026-06-29T21:33:41.630Z","created_at":"2026-06-29T21:33:41.630Z","updated_at":"2026-07-17T02:43:11.676Z","machine":{"shape":"article.machine/v1","slug":"thymosin-alpha-1-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/thymosin-alpha-1-skin","json":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin","bundle":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=thymosin-alpha-1-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"thymosin-alpha-1-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"thymosin-alpha-1-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"thymosin-alpha-1-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/thymosin-alpha-1-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/thymosin-alpha-1-skin","json":"/api/articles/thymosin-alpha-1-skin","markdown":"/api/articles/thymosin-alpha-1-skin/bundle?format=markdown","skill":"/api/articles/thymosin-alpha-1-skin/skill","topology":"/api/articles/thymosin-alpha-1-skin/topology","versions":"/api/articles/thymosin-alpha-1-skin/revisions","invocations":"/api/articles/thymosin-alpha-1-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"thymosin-alpha-1-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"c7601a8139a71b410feb78ea84bfbfa1bbc7e864e4c3796cdb07ddacc26a7612","object":{"object_type":"article-object","identity":{"id":"article:thymosin-alpha-1-skin","slug":"thymosin-alpha-1-skin","title":"Thymosin Alpha 1 for Skin: Evidence-Graded Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/thymosin-alpha-1-skin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/thymosin-alpha-1-skin/skill","role":"direct behavior","audience":"model","content":"---\nname: thymosin-alpha-1-skin\ndescription: Apply the Thymosin Alpha 1 for Skin: Evidence-Graded Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Thymosin Alpha 1 for Skin: Evidence-Graded Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/thymosin-alpha-1-skin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/thymosin-alpha-1-skin.\n- Read claims and relationships at /api/articles/thymosin-alpha-1-skin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Skin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balan\n\n## Representations\n\n- Human: /a/thymosin-alpha-1-skin\n- JSON: /api/articles/thymosin-alpha-1-skin\n- Relationships: /api/articles/thymosin-alpha-1-skin/topology\n- History: /api/articles/thymosin-alpha-1-skin/revisions\n"},"json":{"route":"/api/articles/thymosin-alpha-1-skin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/thymosin-alpha-1-skin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","thymosin","alpha","1","skin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/thymosin-alpha-1-skin/invocations?status=success","failure_events":"/api/articles/thymosin-alpha-1-skin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"thymosin-alpha-1-skin","title":"Thymosin Alpha 1 for Skin: Evidence-Graded Review","body":"## What's breaking down\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\n\n## Why Thymosin Alpha-1 might help you\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\n\n## How these fit together\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\n\n## What the evidence actually shows\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigue or infections.\n\n## What scientists say\nReviews note immune-modulating roles in melanoma and potential for autoimmune skin-related conditions via restored T-cell function and reduced excessive inflammation. Wound-healing data remain animal-based. Larger human trials for dermatologic uses are absent.\n\n## What people say on Reddit\nPosts rarely focus on skin specifically. General peptide discussions mention immune support but lack detailed skin-before/after reports.\n\n## What people say on X\nSparse mentions; no prominent skin-specific anecdotes identified in searches.\n\n## What we do not know\nDirect effects on human skin barrier repair, psoriasis plaques, or chronic wounds lack dedicated trials. Long-term skin outcomes and optimal contexts remain untested in large populations. Correlation of low levels in psoriatic arthritis does not prove causation or treatment effect.\n\n## Safety and limits\nClinical reviews of over 11,000 subjects across trials describe it as generally well-tolerated. No skin-specific safety signals reported in available data. Individual responses vary; consult research literature for full context.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/thymosin-alpha-1-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Serum thymosin alpha-1 levels were significantly lower in psoriatic arthritis patients compared to healthy controls in a 2016 human study of 320 subjects.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Links lower endogenous levels to a skin/joint autoimmune condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Thymosin alpha-1 stimulated endothelial cell migration, angiogenesis, and accelerated wound healing in a 1998 animal study using subcutaneous and topical administration in punch wound models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Provides mechanistic repair data relevant to skin.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In human phase II melanoma trials, thymosin alpha-1 combined with dacarbazine increased objective response rates threefold versus dacarbazine alone.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct human evidence in a skin cancer context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5011367/","title":"Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases","quote":"Patients had lower serum Tα1 levels than HC (p<0.0001), the lowest were observed in PsA group (p< 0.0001 vs all the other groups).","summary":"Human observational study measuring serum TA-1 in autoimmune patients including PsA.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"7bea83a89a395167e60bedffd34ba7c4e01db6d0672c675e9d2d102ed38b4fc8"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9551940/","title":"Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing","quote":"When given either topically or i.p., it accelerated wound healing in a punch model, demonstrating that Talpha1 promotes angiogenesis and wound healing.","summary":"Preclinical animal study on wound healing effects.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"verified","prev":"7bea83a89a395167e60bedffd34ba7c4e01db6d0672c675e9d2d102ed38b4fc8","hash":"da12a15343911d54621558313a10ee808a2238bf213961826a8e2db5dd4c15bd"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/30063847/","title":"Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1","quote":"Thymosin alpha-1 (Tα1) with dacarbazine (DTIC) showed activity in a phase II trial...","summary":"Human clinical data on melanoma response rates.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T22:56:57.133Z","link_status":"ok","quote_status":"unverified","prev":"da12a15343911d54621558313a10ee808a2238bf213961826a8e2db5dd4c15bd","hash":"a37396b83bc22d94c1bd06b4634c2fa17aaa878bbf8ec2cc6e42755fdd997f9f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T22:56:58.308Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Thymosin Alpha 1 for Skin: Evidence-Graded Review","register":"source_ledger","body":"## What's breaking down\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\n\n## Why Thymosin Alpha-1 might help you\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\n\n## How these fit together\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\n\n## What the evidence actually shows\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigue or infections.\n\n## What scientists say\nReviews note immune-modulating roles in melanoma and potential for autoimmune skin-related conditions via restored T-cell function and reduced excessive inflammation. Wound-healing data remain animal-based. Larger human trials for dermatologic uses are absent.\n\n## What people say on Reddit\nPosts rarely focus on skin specifically. General peptide discussions mention immune support but lack detailed skin-before/after reports.\n\n## What people say on X\nSparse mentions; no prominent skin-specific anecdotes identified in searches.\n\n## What we do not know\nDirect effects on human skin barrier repair, psoriasis plaques, or chronic wounds lack dedicated trials. Long-term skin outcomes and optimal contexts remain untested in large populations. Correlation of low levels in psoriatic arthritis does not prove causation or treatment effect.\n\n## Safety and limits\nClinical reviews of over 11,000 subjects across trials describe it as generally well-tolerated. No skin-specific safety signals reported in available data. Individual responses vary; consult research literature for full context.","claims":[{"id":"c1","text":"Serum thymosin alpha-1 levels were significantly lower in psoriatic arthritis patients compared to healthy controls in a 2016 human study of 320 subjects.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Links lower endogenous levels to a skin/joint autoimmune condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Thymosin alpha-1 stimulated endothelial cell migration, angiogenesis, and accelerated wound healing in a 1998 animal study using subcutaneous and topical administration in punch wound models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Provides mechanistic repair data relevant to skin.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In human phase II melanoma trials, thymosin alpha-1 combined with dacarbazine increased objective response rates threefold versus dacarbazine alone.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Direct human evidence in a skin cancer context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:56:57.688Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5011367/","title":"Serum thymosin α1 levels in patients with chronic inflammatory autoimmune diseases","quote":"Patients had lower serum Tα1 levels than HC (p<0.0001), the lowest were observed in PsA group (p< 0.0001 vs all the other groups).","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/9551940/","title":"Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing","quote":"When given either topically or i.p., it accelerated wound healing in a punch model, demonstrating that Talpha1 promotes angiogenesis and wound healing.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/30063847/","title":"Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1","quote":"Thymosin alpha-1 (Tα1) with dacarbazine (DTIC) showed activity in a phase II trial...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":31088,"tokens_out":2495,"cost":0.0450975,"prev_hash":"genesis","hash":"11da711b6a9f4bf9db5bb6f47a3eb26896655b566d0aeee2d0a256f7715c6f55"}],"provenance":[{"ts":"2026-06-29T22:56:58.308Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Thymosin Alpha 1 for Skin\nSlug: thymosin-alpha-1-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"thymosin-alpha-1\",\"name\":\"Thymosin Alpha-1\",\"section_title\":\"Why Thymosin Alpha-1 might help you\",\"layer\":\"immune modulation\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Thymosin Alpha-1 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Thymosin Alpha-1** → immune modulation\",\"section_headings\":[\"What's breaking down\",\"Why Thymosin Alpha-1 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chai","response":"{\n  \"slug\": \"thymosin-alpha-1-skin\",\n  \"title\": \"Thymosin Alpha 1 for Skin: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\nSkin health depends on balanced immune surveillance, timely tissue repair, and controlled inflammation. When immune modulation falters, layers such as endothelial migration for new vessel growth, regulatory T-cell balance, and cytokine signaling can degrade. This allows chronic inflammation or slowed wound closure to outpace repair. Thymosin Alpha-1 is discussed here for its studied effects on immune restoration rather than symptom masking.\\n\\n## Why Thymosin Alpha-1 might help you\\nThymosin Alpha-1 targets immune pathways tied to tissue repair. If your skin issue involves impaired angiogenesis or immune cell coordination, the peptide is examined because it supports restoration of these functions. Step 1: It influences T-cell maturation and dendritic cell activity. Step 2: This can promote endothelial cell migration. Step 3: Resulting angiogenesis supports wound closure in models. Therefore, for skin layers where repair lags due to immune deficits, it is studied for direct support of those pathways.\\n\\n## How these fit together\\nSingle-compound focus. Thymosin Alpha-1 addresses immune modulation as the primary layer for skin repair contexts.\\n\\n## What the evidence actually shows\\nHuman data: One study measured serum levels in 120 psoriatic arthritis patients versus controls and found significantly lower thymosin alpha-1 in patients (preclinical and mechanistic links to skin autoimmunity). Melanoma trials (human, phase II) showed improved response rates when combined with dacarbazine. Preclinical: 1998 study demonstrated stimulation of endothelial migration, angiogenesis, and accelerated wound healing in animal punch models (topical or systemic). No large human trials specifically for common skin conditions like psoriasis or wounds. Anecdotal: Limited Reddit or X reports tied directly to skin outcomes; most anecdotes concern fatigu","tokens_in":31088,"tokens_out":2495,"cost":0,"prev":"genesis","hash":"57b599aefb0c610213a5630d465eb2a6100861d2c80e15ecebc896ce66f6070a"},{"ts":"2026-07-17T02:43:11.676Z","model":"owner","action":"voxel_divide","prompt":"","input":"thymosin-alpha-1-skin","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"57b599aefb0c610213a5630d465eb2a6100861d2c80e15ecebc896ce66f6070a","hash":"8c4657b588cb633087370631c4d68c26ef95d553ce47b4ebf702bd5abccbb672"}],"energy":{"passes":2,"tokens_in":31088,"tokens_out":2495,"tokens_total":33583,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8c4657b588cb633087370631c4d68c26ef95d553ce47b4ebf702bd5abccbb672"},"posted_at":"2026-06-29T21:33:41.630Z","created_at":"2026-06-29T21:33:41.630Z","updated_at":"2026-07-17T02:43:11.676Z","machine":{"shape":"article.machine/v1","slug":"thymosin-alpha-1-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/thymosin-alpha-1-skin","json":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin","bundle":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=thymosin-alpha-1-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"thymosin-alpha-1-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"thymosin-alpha-1-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/thymosin-alpha-1-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"thymosin-alpha-1-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/thymosin-alpha-1-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/thymosin-alpha-1-skin","json":"/api/articles/thymosin-alpha-1-skin","markdown":"/api/articles/thymosin-alpha-1-skin/bundle?format=markdown","skill":"/api/articles/thymosin-alpha-1-skin/skill","topology":"/api/articles/thymosin-alpha-1-skin/topology","versions":"/api/articles/thymosin-alpha-1-skin/revisions","invocations":"/api/articles/thymosin-alpha-1-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"thymosin-alpha-1-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"c7601a8139a71b410feb78ea84bfbfa1bbc7e864e4c3796cdb07ddacc26a7612"}}}